{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T19:59:19Z","timestamp":1772913559957,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007437","name":"TrygFonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007437","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Imk Almene Fond"},{"name":"NovVac ApS"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.vaccine.2016.07.016","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T05:30:23Z","timestamp":1470288623000},"page":"4602-4609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Proteome-wide antigen discovery of novel protective vaccine candidates against Staphylococcus aureus infection"],"prefix":"10.1016","volume":"34","author":[{"given":"Karina Juhl","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas Holm","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrine","family":"Pilely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilie Antoinette","family":"Asferg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana","family":"Ciofu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Vitved","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.07.016_b0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.10.3.505","article-title":"Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks","volume":"10","author":"Kluytmans","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.07.016_b0010","unstructured":"Prevention CfDCa. Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Dialysis Patients \u2013- United States, 2005. Morbidity and Mortality Weekly Report (MMWR). 2007; March 9, 2007. p. 197\u20139."},{"key":"10.1016\/j.vaccine.2016.07.016_b0015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/499398a","article-title":"Farming up trouble","volume":"499","author":"Mole","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.07.016_b0020","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00082-12","article-title":"Human origin for livestock-associated methicillin-resistant Staphylococcus aureus","volume":"3","author":"Fitzgerald","year":"2012","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2016.07.016_b0025","article-title":"Human infections with staphylococcusaureus CC398","volume":"11","author":"Smith","year":"2015","journal-title":"Curr Environ Health Rpt"},{"key":"10.1016\/j.vaccine.2016.07.016_b0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0966-842X(94)90617-3","article-title":"Expression of resistance to methicillin","volume":"2","author":"Berger-Bachi","year":"1994","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2016.07.016_b0035","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1517\/14656566.8.9.1245","article-title":"Vancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections","volume":"8","author":"Pope","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.vaccine.2016.07.016_b0040","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.20092514","article-title":"Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice","volume":"207","author":"Kim","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.07.016_b0045","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2016.07.016_b0050","article-title":"Vaccination and passive immunisation against Staphylococcus aureus","volume":"32","author":"Schaffer","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.vaccine.2016.07.016_b0055","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1073\/pnas.1424924112","article-title":"Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus","volume":"112","author":"Bagnoli","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.07.016_b0060","first-page":"80","article-title":"In silico prediction of Gallibacterium anatis pan-immunogens","volume":"45","author":"Bager","year":"2014","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2016.07.016_b0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Flower","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.vaccine.2016.07.016_b0070","doi-asserted-by":"crossref","first-page":"9786","DOI":"10.1073\/pnas.0402521101","article-title":"Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance","volume":"101","author":"Holden","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.07.016_b0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0022-2836(81)90087-5","article-title":"Identification of common molecular subsequences","volume":"147","author":"Smith","year":"1981","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2016.07.016_b0080","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1128\/AAC.00096-06","article-title":"Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of staphylococcus aureus bacteremia","volume":"50","author":"John Weems","year":"2006","journal-title":"Antimicrob Agents Chemotherapy"},{"key":"10.1016\/j.vaccine.2016.07.016_b0085","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1128\/AAC.00570-07","article-title":"Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia","volume":"51","author":"Rupp","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2016.07.016_b0090","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.jp.7211496","article-title":"A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin","volume":"26","author":"Benjamin","year":"2006","journal-title":"J Perinatol"},{"key":"10.1016\/j.vaccine.2016.07.016_b0095","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jpeds.2007.04.060","article-title":"Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants","volume":"151","author":"DeJonge","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2016.07.016_b0100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa011297","article-title":"Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis","volume":"346","author":"Shinefield","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.07.016_b0105","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/jama.2013.3010","article-title":"Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial","volume":"309","author":"Fowler","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.07.016_b0110","series-title":"Vaccine-based strategies for prevention of staphylococcal disease","author":"Lee","year":"1997"},{"key":"10.1016\/j.vaccine.2016.07.016_b0115","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1086\/324430","article-title":"Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant","volume":"184","author":"Josefsson","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.016_b0120","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1073\/pnas.092569199","article-title":"Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus","volume":"99","author":"Etz","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.07.016_b0125","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/1615-9861(200205)2:5<580::AID-PROT580>3.0.CO;2-G","article-title":"Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis","volume":"2","author":"Vytvytska","year":"2002","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2016.07.016_b0130","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1128\/IAI.68.6.3200-3209.2000","article-title":"Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections","volume":"68","author":"Burnie","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.07.016_b0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.diagmicrobio.2011.03.010","article-title":"USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections?","volume":"70","author":"Kreisel","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.016_b0140","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3201\/eid1409.071576","article-title":"Pigs as source of methicillin-resistant Staphylococcus aureus CC398 infections in humans","volume":"14","author":"Lewis","year":"2008","journal-title":"Denmark Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.016_b0145","doi-asserted-by":"crossref","first-page":"e1000703","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice","volume":"5","author":"Lin","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.07.016_b0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-065X.2008.00699.x","article-title":"The roles of IL-17A in inflammatory immune responses and host defense against pathogens","volume":"226","author":"Iwakura","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2016.07.016_b0155","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nri3010","article-title":"Immunity against Staphylococcus aureus cutaneous infections","volume":"11","author":"Miller","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.07.016_b0160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00281-011-0293-5","article-title":"Development of a vaccine against Staphylococcus aureus","volume":"34","author":"Spellberg","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2016.07.016_b0165","doi-asserted-by":"crossref","first-page":"e1005226","DOI":"10.1371\/journal.ppat.1005226","article-title":"Memory Th1 cells are protective in invasive staphylococcus aureus infection","volume":"11","author":"Brown","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.07.016_b0170","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.meegid.2008.09.012","article-title":"Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus","volume":"9","author":"van Belkum","year":"2009","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2016.07.016_b0175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1574-6976.2009.00202.x","article-title":"How microorganisms avoid phagocyte attraction","volume":"34","author":"Bestebroer","year":"2010","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.07.016_b0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00109-009-0572-y","article-title":"Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications","volume":"88","author":"Laarman","year":"2010","journal-title":"J Mol Med (Berl)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16305898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16305898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T19:15:25Z","timestamp":1600974925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16305898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":36,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0264410X16305898"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteome-wide antigen discovery of novel protective vaccine candidates against Staphylococcus aureus infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}